Last reviewed · How we verify

NCT04129827: LCA-40

Meniscal Lesions in Return to Sport After Anterior Cruciate Ligament Reconstruction

Completed Last updated 8 October 2021
What this trial tests

trial testing Clinical, self-reported psychological and biomechanical assessments in ACL Injury in 20 participants. Completed in 31 December 2019.

Timeline
1 July 2018
Primary endpoint
21 December 2018
31 December 2019

Quick facts

Lead sponsorUniversity of Bari
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date1 July 2018
Primary completion21 December 2018
Estimated completion31 December 2019
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Bari

Who can join

Adults 18 to 35, any sex, with ACL Injury or Meniscus Lesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Most athletes who undergo Anterior Cruciate Ligament Reconstruction (ACLR) plan to return to some level of sporting (RTS) activity. However, rates of return to pre-injury sport are often less than might be expected and many factors influence whether individuals return to sport after this surgery. This study aims to better understand the role of meniscal lesions in RTS and to assess the advantage of the integrated evaluation with clinical, biomechanical and psychological tests to decide the correct RTS timing in non-professional athletes undergoing ACLR.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical, Biomechanical, and Self-reported Health Status After ACL Reconstruction With Meniscal Repair in Soccer Players: Results at Minimum 1-Year Follow-up.
    Moretti L, Bortone I, Delmedico M, Cassano DG, et al · · 2023 · cited 3× · PMID 37547078 · DOI 10.1177/23259671231177309

Verify or expand the search:

Other recruiting trials for ACL Injury

Currently open trials in the same condition.

Other University of Bari trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04129827.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing